Format
Sort by
Items per page

Send to

Choose Destination

Best matches for La Rosée P[au]:

Search results

Items: 1 to 50 of 78

1.

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry.

Birndt S, Schenk T, Heinevetter B, Brunkhorst FM, Maschmeyer G, Rothmann F, Weber T, Müller M, Panse J, Penack O, Schroers R, Braess J, Frickhofen N, Ehl S, Janka G, Lehmberg K, Pletz MW, Hochhaus A, Ernst T, La Rosée P.

J Cancer Res Clin Oncol. 2020 Feb 20. doi: 10.1007/s00432-020-03139-4. [Epub ahead of print]

PMID:
32076823
2.

Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.

Schmitz C, Rekowski J, Müller SP, Hertenstein B, Franzius C, Ganser A, Bengel FM, Kroschinsky F, Kotzerke J, La Rosée P, Freesmeyer M, Hoeffkes HG, Hertel A, Behringer D, Mesters R, Weckesser M, Mahlmann S, Haberkorn U, Martens U, Prange-Krex G, Brenner W, Giagounidis A, Moeller R, Runde V, Sandmann M, Hautzel H, Wilop S, Krohn T, Dürk H, Heike M, Alashkar F, Brinkmann M, Trenn G, Wacker D, Kreisel-Büstgens C, Bernhard H, Heil G, Larisch R, Kurch L, Jöckel KH, Hoelzer D, Klapper W, Boellaard R, Dührsen U, Hüttmann A.

Hematol Oncol. 2020 Feb 18. doi: 10.1002/hon.2697. [Epub ahead of print]

PMID:
32067259
3.

Hyperferritinemia in Critically Ill Patients.

Lachmann G, Knaak C, Vorderwülbecke G, La Rosée P, Balzer F, Schenk T, Schuster FS, Nyvlt P, Janka G, Brunkhorst FM, Keh D, Spies C.

Crit Care Med. 2019 Dec 24. doi: 10.1097/CCM.0000000000004131. [Epub ahead of print]

PMID:
31876528
4.

Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocol.

Lachmann G, Knaak C, von Haefen C, Paeschke N, Meisel C, Nyvlt P, Schuster FS, Piper SK, Kruppa J, Vorderwülbecke G, Balzer F, La Rosée P, Schenk T, Unterwalder N, Kölsch U, Lachmann N, Akyüz L, Brunkhorst FM, Volk HD, Keh D, Spies C.

BMJ Open. 2019 Oct 30;9(10):e032695. doi: 10.1136/bmjopen-2019-032695.

5.

Current gaps in sepsis immunology: new opportunities for translational research.

Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, La Rosée P, Monneret G, Venet F, Bauer M, Brunkhorst FM, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Martin-Fernandez M, Almansa R, Martin-Loeches I, Torres A, Giamarellos-Bourboulis EJ, Girardis M, Cossarizza A, Netea MG, van der Poll T, Scherag A, Meisel C, Schefold JC, Bermejo-Martín JF.

Lancet Infect Dis. 2019 Dec;19(12):e422-e436. doi: 10.1016/S1473-3099(19)30567-5. Epub 2019 Oct 17. Review.

PMID:
31630991
6.

Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.

Knaak C, Schuster FS, Spies C, Vorderwülbecke G, Nyvlt P, Schenk T, Balzer F, La Rosée P, Janka G, Brunkhorst FM, Keh D, Lachmann G.

Shock. 2019 Oct 15. doi: 10.1097/SHK.0000000000001454. [Epub ahead of print]

PMID:
31626037
7.

Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.

Saussele S, Haverkamp W, Lang F, Koschmieder S, Kiani A, Jentsch-Ullrich K, Stegelmann F, Pfeifer H, La Rosée P, Goekbuget N, Rieger C, Waller CF, Franke GN, le Coutre P, Kirchmair R, Junghanss C.

Acta Haematol. 2019 Oct 7:1-15. doi: 10.1159/000501927. [Epub ahead of print] Review.

8.

[Hemophagocytic lymphohistiocytosis in unspecific virus infection].

Lachmann G, Knaak C, La Rosée P, Spies C, Nyvlt P, Oberender C, Sander LE, Suttorp N, Müller-Redetzky H.

Anaesthesist. 2019 Sep;68(9):626-632. doi: 10.1007/s00101-019-00634-3. Epub 2019 Aug 8. German.

PMID:
31396675
9.

Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.

La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G, Henter JI.

Blood. 2019 Jun 6;133(23):2465-2477. doi: 10.1182/blood.2018894618. Epub 2019 Apr 16.

PMID:
30992265
10.

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.

Hüttmann A, Rekowski J, Müller SP, Hertenstein B, Franzius C, Mesters R, Weckesser M, Kroschinsky F, Kotzerke J, Ganser A, Bengel FM, La Rosée P, Freesmeyer M, Höffkes HG, Hertel A, Behringer D, Prange-Krex G, Griesshammer M, Holzinger J, Wilop S, Krohn T, Raghavachar A, Maschmeyer G, Brink I, Schroers R, Gaska T, Bernhard H, Giagounidis A, Schütte J, Dienst A, Hautzel H, Naumann R, Klein A, Hahn D, Pöpperl G, Grube M, Marienhagen J, Schwarzer A, Kurch L, Höhler T, Steiniger H, Nückel H, Südhoff T, Römer W, Brinkmann M, Ose C, Alashkar F, Schmitz C, Dürig J, Hoelzer D, Jöckel KH, Klapper W, Dührsen U.

Ann Hematol. 2019 Apr;98(4):897-907. doi: 10.1007/s00277-018-3578-0. Epub 2019 Jan 4.

PMID:
30610279
11.

Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.

Ehl S, Astigarraga I, von Bahr Greenwood T, Hines M, Horne A, Ishii E, Janka G, Jordan MB, La Rosée P, Lehmberg K, Machowicz R, Nichols KE, Sieni E, Wang Z, Henter JI.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1508-1517. doi: 10.1016/j.jaip.2018.05.031. Epub 2018 Jul 4. Review.

PMID:
30201097
12.

Hemophagocytic Lymphohistiocytosis: Potentially Underdiagnosed in Intensive Care Units.

Lachmann G, Spies C, Schenk T, Brunkhorst FM, Balzer F, La Rosée P.

Shock. 2018 Aug;50(2):149-155. doi: 10.1097/SHK.0000000000001048.

PMID:
30010630
13.

Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.

Dührsen U, Müller S, Hertenstein B, Thomssen H, Kotzerke J, Mesters R, Berdel WE, Franzius C, Kroschinsky F, Weckesser M, Kofahl-Krause D, Bengel FM, Dürig J, Matschke J, Schmitz C, Pöppel T, Ose C, Brinkmann M, La Rosée P, Freesmeyer M, Hertel A, Höffkes HG, Behringer D, Prange-Krex G, Wilop S, Krohn T, Holzinger J, Griesshammer M, Giagounidis A, Raghavachar A, Maschmeyer G, Brink I, Bernhard H, Haberkorn U, Gaska T, Kurch L, van Assema DME, Klapper W, Hoelzer D, Geworski L, Jöckel KH, Scherag A, Bockisch A, Rekowski J, Hüttmann A; PETAL Trial Investigators.

J Clin Oncol. 2018 Jul 10;36(20):2024-2034. doi: 10.1200/JCO.2017.76.8093. Epub 2018 May 11.

PMID:
29750632
14.

Consensus statement for cancer patients requiring intensive care support.

Kiehl MG, Beutel G, Böll B, Buchheidt D, Forkert R, Fuhrmann V, Knöbl P, Kochanek M, Kroschinsky F, La Rosée P, Liebregts T, Lück C, Olgemoeller U, Schalk E, Shimabukuro-Vornhagen A, Sperr WR, Staudinger T, von Bergwelt Baildon M, Wohlfarth P, Zeremski V, Schellongowski P; Consensus of the German Society of Hematology and Medical Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN).

Ann Hematol. 2018 Jul;97(7):1271-1282. doi: 10.1007/s00277-018-3312-y. Epub 2018 Apr 27.

15.

[Rheumatoid symptoms in patients with hematologic neoplasms].

Kleinert S, La Rosée P, Krüger K.

Z Rheumatol. 2017 Oct;76(Suppl 2):38-45. doi: 10.1007/s00393-017-0338-9. Review. German.

PMID:
29330756
16.

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

PMID:
29054815
17.

A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.

Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM.

Cancer. 2017 Sep 1;123(17):3229-3240. doi: 10.1002/cncr.30826. Epub 2017 Jun 16. Review.

18.

Rescue of Cytokine Storm Due to HLH by Hemoadsorption in a CTLA4-Deficient Patient.

Greil C, Roether F, La Rosée P, Grimbacher B, Duerschmied D, Warnatz K.

J Clin Immunol. 2017 Apr;37(3):273-276. doi: 10.1007/s10875-017-0377-7. Epub 2017 Mar 6. No abstract available.

PMID:
28265964
19.

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ.

Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.

PMID:
27989379
20.

[Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Lachmann G, La Rosée P, Schenk T, Brunkhorst FM, Spies C.

Anaesthesist. 2016 Oct;65(10):776-786. Review. German.

PMID:
27612865
21.

[Hemophagocytic lymphohistiocytosis in adults].

Schenk T, La Rosée P.

Dtsch Med Wochenschr. 2016 Aug;141(16):1141-3. doi: 10.1055/s-0042-107376. Epub 2016 Aug 10. German.

PMID:
27509340
22.

Alleviating the storm: ruxolitinib in HLH.

La Rosée P.

Blood. 2016 Mar 31;127(13):1626-7. doi: 10.1182/blood-2016-02-697151.

PMID:
27034417
23.

A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.

Hunstig F, Schulz S, Nieten I, Froster U, Boltze C, Schliemann S, Hochhaus A, La Rosée P.

J Cancer Res Clin Oncol. 2016 Apr;142(4):845-8. doi: 10.1007/s00432-015-2079-y. Epub 2015 Dec 11.

PMID:
26660106
24.

Treatment of hemophagocytic lymphohistiocytosis in adults.

La Rosée P.

Hematology Am Soc Hematol Educ Program. 2015;2015:190-6. doi: 10.1182/asheducation-2015.1.190.

PMID:
26637720
25.

First prospective clinical trial in adult HLH.

La Rosée P.

Blood. 2015 Nov 5;126(19):2169-71. doi: 10.1182/blood-2015-09-666503. No abstract available.

PMID:
26542249
26.

Successful treatment of neutropenic MRSA bacteremia with septic superior vena cava thrombus and cerebral embolism using high-dose daptomycin.

Schrenk KG, Frosinski J, Scholl S, Otto S, La Rosée P, Hochhaus A, Pletz MW.

Ann Hematol. 2016 Jan;95(2):355-7. No abstract available.

PMID:
26490881
27.

Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.

Lehmberg K, Nichols KE, Henter JI, Girschikofsky M, Greenwood T, Jordan M, Kumar A, Minkov M, La Rosée P, Weitzman S; Study Group on Hemophagocytic Lymphohistiocytosis Subtypes of the Histiocyte Society.

Haematologica. 2015 Aug;100(8):997-1004. doi: 10.3324/haematol.2015.123562.

28.

Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.

Richter ME, Neugebauer S, Engelmann F, Hagel S, Ludewig K, La Rosée P, Sayer HG, Hochhaus A, von Lilienfeld-Toal M, Bretschneider T, Pausch C, Engel C, Brunkhorst FM, Kiehntopf M.

Infection. 2016 Apr;44(2):175-86. doi: 10.1007/s15010-015-0830-6. Epub 2015 Aug 15.

PMID:
26275448
29.

[Chronic myelogenous leukemia].

Hochhaus A, La Rosée P, Eigendorff E, Ernst T.

Internist (Berl). 2015 Apr;56(4):333-43. doi: 10.1007/s00108-014-3594-7. German.

PMID:
25860113
30.

Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients.

Hochhaus A, Ernst T, Eigendorff E, La Rosée P.

Ann Hematol. 2015 Apr;94 Suppl 2:S133-40. doi: 10.1007/s00277-015-2323-1. Epub 2015 Mar 27. Review.

PMID:
25814079
31.

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.

Frietsch JJ, Kastner C, Grunewald TG, Schweigel H, Nollau P, Ziermann J, Clement JH, La Rosée P, Hochhaus A, Butt E.

Oncotarget. 2014 Jul 30;5(14):5257-71.

32.

Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML).

Schnetzke U, Fix P, Spies-Weisshart B, Schrenk K, Glaser A, Fricke HJ, La Rosée P, Hochhaus A, Scholl S.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1391-7. doi: 10.1007/s00432-014-1666-7. Epub 2014 Apr 12.

PMID:
24728467
33.

Fulminant gastrointestinal bleeding caused by EBV-triggered hemophagocytic lymphohistiocytosis: report of a case.

Klein S, Schmidt C, La Rosée P, Pletz M, Harz S, Dirsch O, Fritzenwanger M, Stallmach A.

Z Gastroenterol. 2014 Apr;52(4):354-9. doi: 10.1055/s-0034-1366154. Epub 2014 Apr 9.

PMID:
24718941
34.

Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.

Frietsch JJ, Dornaus S, Neumann T, Scholl S, Schmidt V, Kunert C, Sayer HG, Hochhaus A, La Rosée P.

Eur J Haematol. 2014 Sep;93(3):247-59. doi: 10.1111/ejh.12311. Epub 2014 Apr 9. Review.

PMID:
24635656
35.

Complete remission after treatment with single-agent ofatumumab in a patient with high-risk leukemic mantle-cell lymphoma.

Hunstig F, Hammersen J, Kunert C, Petersen I, Merz H, Glaser A, Teichgräber U, Hochhaus A, La Rosée P.

J Clin Oncol. 2013 Jul 1;31(19):e312-5. doi: 10.1200/JCO.2012.45.9438. Epub 2013 May 20. No abstract available.

PMID:
23690428
36.

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib.

La Rosée P, Martiat P, Leitner A, Klag T, Müller MC, Erben P, Schenk T, Saussele S, Hochhaus A.

Ann Hematol. 2013 Oct;92(10):1345-50. doi: 10.1007/s00277-013-1769-2. Epub 2013 Apr 28.

PMID:
23625298
37.

Paradoxical MAPK-activation in response to treatment with tyrosine kinase inhibitors in CML: flow cytometry loses track.

Schnetzke U, Fischer M, Frietsch JJ, Finkensieper A, Clement JH, Hochhaus A, La Rosée P.

Cytometry B Clin Cytom. 2014 Jul;86(4):229-35. doi: 10.1002/cyto.b.21091. Epub 2013 Apr 10.

38.

Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany.

Heublein S, Wehner F, Höchsmann B, Hochhaus A, Hartmann M, La Rosée P.

Ann Hematol. 2013 Jun;92(6):825-30. doi: 10.1007/s00277-013-1688-2. Epub 2013 Feb 13.

PMID:
23404582
39.

[Tailored management of chronic myeloid leukemia].

Hochhaus A, La Rosée P.

Internist (Berl). 2013 Feb;54(2):155-6, 158-60, 162-3. doi: 10.1007/s00108-012-3152-0. German.

PMID:
23371258
40.

Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting.

Witzens-Harig M, Hess G, Atta J, Zaiss M, Lenz G, Scholz C, Repp R, Reiser M, Pott C, Pelz H, La Rosée P, Kirchner H, Kiewe P, Keller U, Buske C, Viardot A, Dreyling M.

Ann Hematol. 2012 Nov;91(11):1765-72. doi: 10.1007/s00277-012-1534-y. Epub 2012 Aug 29. Review.

PMID:
22926531
41.

Fulminant Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Bohne S, Kentouche K, Petersen I, Fritzenwanger M, Pletz MW, Lehmberg K, La Rosée P, Guntinas-Lichius O.

Laryngoscope. 2013 Feb;123(2):362-5. doi: 10.1002/lary.23433. Epub 2012 May 30.

PMID:
22648663
42.

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors.

Klag T, Härtel N, Erben P, Schwaab J, Schnetzke U, Schenk T, Hochhaus A, La Rosée P.

Leukemia. 2012 Jun;26(6):1321-8. doi: 10.1038/leu.2011.380. Epub 2012 Jan 13.

PMID:
22289991
43.

Imatinib and beyond--targeting activated tyrosine kinases in myeloproliferative disorders.

Hochhaus A, Reiter A, Ernst T, La Rosée P.

Onkologie. 2012;35 Suppl 1:34-41. doi: 10.1159/000334824. Epub 2012 Jan 20.

PMID:
22286586
44.

Rapid treatment of leukostasis in leukemic mantle cell lymphoma using therapeutic leukapheresis: a case report.

Nguyen XD, La Rosée P, Nebe T, Klüter H, Buchheidt D.

ScientificWorldJournal. 2011;11:1554-9. doi: 10.1100/tsw.2011.142.. Epub 2011 Aug 16.

45.

Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity.

Härtel N, Klag T, Hanfstein B, Mueller MC, Schenk T, Erben P, Hochhaus A, La Rosée P.

J Cancer Res Clin Oncol. 2012 Feb;138(2):203-12. doi: 10.1007/s00432-011-1086-x. Epub 2011 Nov 17.

PMID:
22089930
46.

BCR-ABL mutations in chronic myeloid leukemia.

Ernst T, La Rosée P, Müller MC, Hochhaus A.

Hematol Oncol Clin North Am. 2011 Oct;25(5):997-1008, v-vi. doi: 10.1016/j.hoc.2011.09.005. Review.

PMID:
22054731
47.

Leriche's syndrome and Löffler endocarditis in a 30-year-old patient presenting with hypereosinophilic syndrome.

Klag T, Schnetzke U, Benz R, Zanow J, Glaser A, Pörner TC, Scholl S, Reiter A, Hochhaus A, La Rosée P.

Ann Hematol. 2012 Jan;91(1):139-41. doi: 10.1007/s00277-011-1232-1. Epub 2011 Apr 15. No abstract available.

PMID:
21494797
48.

Drug-induced lymphadenopathy with eosinophilia and renal failure mimicking lymphoma disease: dramatic onset of DRESS syndrome associated with antibiotic treatment.

Schnetzke U, Bossert T, Scholl S, Freesmeyer M, Hochhaus A, La Rosée P.

Ann Hematol. 2011 Nov;90(11):1353-5. doi: 10.1007/s00277-011-1170-y. Epub 2011 Feb 5. No abstract available.

PMID:
21298267
49.

Impact of BCR-ABL mutations on patients with chronic myeloid leukemia.

Hochhaus A, La Rosée P, Müller MC, Ernst T, Cross NC.

Cell Cycle. 2011 Jan 15;10(2):250-60. Epub 2011 Jan 15. Review.

PMID:
21220945
50.

Ornithine transcarbamylase (OTC) deficiency based on a hemizygous p.R277W mutation causing life-threatening hyperammonemic crisis during treatment for Hodgkin's lymphoma.

Ritter E, Husain RA, Hinderhofer K, Prell T, Fricke HJ, Scholl S, Hochhaus A, La Rosée P.

Ann Hematol. 2011 Jul;90(7):857-9. doi: 10.1007/s00277-010-1106-y. No abstract available.

PMID:
21061009

Supplemental Content

Loading ...
Support Center